Nutanix, Inc. — Form 10-Q summary
Period clarification: The filing covers the fiscal quarter ended April 30, 2022 (Nutanix fiscal 2022 Q3), not 2021 Q3 as indicated in the request metadata. Comparative figures are for the quarter and nine months ended April 30, 2021. Dollar amounts below are in millions unless stated otherwise.
Business context
Nutanix provides enterprise-cloud software and services for private, hybrid and multicloud environments. Sales are primarily through channel and OEM partners. The company is transitioning toward subscription-based software and SaaS offerings; subscription revenue was about 92% of Q3 revenue.
Financial and operating metrics
| Metric | Q3 FY22 | Q3 FY21 | Nine months FY22 | Nine months FY21 |
|---|---|---|---|---|
| Revenue | $403.7 | $344.5 | $1,195.3 | $1,003.6 |
| Gross profit / margin | $323.8 / 80.2% | $270.0 / 78.4% | $954.0 / 79.8% | $790.3 / 78.7% |
| Operating loss | $(92.3) | $(180.6) | $(324.0) | $(518.9) |
| Net loss | $(111.6) | $(123.6) | $(646.5) | $(676.1) |
| Diluted net loss per share | $(0.50) | $(0.60) | $(2.95) | $(3.31) |
| Operating cash flow | $(3.2) | $(55.6) | $29.5 | $(75.2) |
| Free cash flow, non-GAAP | $(20.1) | $(71.5) | $(4.7) | $(116.3) |
Q3 revenue grew 17% year over year; product revenue increased 16% and support, entitlements and other services revenue increased 18%. Q3 billings were $448.0 million, ACV billings $204.7 million, ARR $1.114 billion, and deferred revenue $1.432 billion. These billings and recurring-revenue measures are company-defined performance metrics, not GAAP measures.
At April 30, 2022, cash and cash equivalents were $386.7 million and short-term investments were $913.9 million, for combined cash, equivalents and investments of $1.301 billion. Current assets were $1.676 billion versus current liabilities of $1.136 billion. Convertible notes had a $1.291 billion carrying value; contractual principal, including accrued PIK interest, was about $1.499 billion. Stockholders’ deficit was $721.9 million.
Material changes and unusual items
- Nine-month revenue rose 19%, gross margin improved 1.1 percentage points and operating loss narrowed by $194.9 million. Net loss narrowed by $29.5 million.
- Operating cash flow improved by $104.7 million for the nine-month period, primarily reflecting increased cash collections. Nine-month free cash flow remained slightly negative.
- Operating expenses were lower overall: Q3 sales and marketing expense fell 11% year over year, while R&D and G&A were also lower for the quarter. Management attributed the sales and marketing decline mainly to lower marketing costs and reduced headcount.
- The company exchanged $416.5 million of 2023 notes for $477.3 million of 2027 notes and recorded a $64.9 million debt-extinguishment loss during the nine months. The 2023 notes’ remaining $145.7 million principal is due in January 2023.
- Adoption of convertible-debt accounting guidance and reclassification of the 2026 notes’ conversion feature materially changed balance-sheet equity classifications; the reclassification was not a cash inflow.
Outlook, risks and contingencies
- Management said unexpected hardware supply-chain delays late in the quarter pushed more orders into future quarters and led some customers to defer software purchases until hardware is available. It expected this trend to continue in the July 2022 quarter and potentially beyond, affecting ACV billings and revenue. No numerical forward guidance is provided in the supplied filing text.
- Management expects operating and free cash flow to fluctuate during the next 12 months, but believes available cash, equivalents and short-term investments are sufficient for anticipated needs over at least that period.
- Risks include reliance on OEMs and hardware availability, sales-representative attrition and below-target sales headcount, subscription-transition effects on billings and cash flow, COVID-19-related uncertainty, and competition and changing customer demand.
- The company disclosed securities and options class actions. Mediation did not produce a settlement; Nutanix recorded an accrual based on its settlement offer and a corresponding estimated insurance recovery. The filing says both estimates may change and actual amounts may differ significantly; it does not provide the accrual or recovery values in the supplied text.
- Non-cancelable purchase obligations and other commitments were up to $99.1 million, with up to $89.6 million in OEM guarantees. The company reported no other material legal proceedings and no off-balance-sheet arrangements.
Important facts for investors to verify
- Confirm whether hardware delays persisted after the filing date and their subsequent effect on orders, ACV billings and recognized revenue.
- Track cash conversion, free cash flow and liquidity alongside subscription growth and deferred revenue; reported operating cash flow and free cash flow differ materially by period.
- Review the terms and settlement approach for the $145.7 million 2023 notes due January 2023, as well as the conversion, maturity and cash-interest implications of the 2026 and 2027 notes.
- Check subsequent disclosures for developments in the class actions, the recorded contingency accrual and insurance recovery.
- Assess whether sales-team attrition and hiring/ramp rates affect growth, and compare company-defined billings and ARR metrics with GAAP revenue and cash flow.